Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Foreign Investors Up Stakes In Nine of 11 Bioventures in Japan (Japan)

This article was originally published in PharmAsia News

Executive Summary

An increase in international investment has provided a much-needed boost to 9 of 11 Japanese biotechnology ventures. Even though many of these companies are losing money, foreign investment continues thanks to the promising new drugs they have in development. "Foreign institutional investors are favoring firms with a hand in developing promising drugs, even though they are bleeding red ink," says Kiyokazu Yamazaki at Ichiyoshi Research Institute Inc. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts